1312424-26-2 Usage
Description
Rilpivirine-d6, a labelled novel non-nucleoside reverse transcriptase inhibitor, is an off-white to pale yellow solid. It is designed for use as an internal standard in the quantification of Rilpivirine by gas chromatography (GC) or liquid chromatography (LC) mass spectrometry. Rilpivirine-d6 is well-tolerated, with less central nervous system (CNS) disturbance than Efavirenz, and has non-teratogenic potential, making it a promising anti-HIV agent.
Uses
Used in Pharmaceutical Industry:
Rilpivirine-d6 is used as an internal standard for the quantification of Rilpivirine by GCor LC-mass spectrometry. This application is crucial for ensuring accurate and reliable measurements of Rilpivirine in various pharmaceutical formulations and research studies.
Used in HIV Treatment:
Rilpivirine-d6 is used as an anti-HIV agent, providing an alternative to Efavirenz with less CNS disturbance and non-teratogenic potential. This makes it a valuable option for patients seeking effective HIV treatment with fewer side effects.
Used in Research and Development:
Rilpivirine-d6 is used as a research tool in the development of new anti-HIV drugs and therapies. Its well-tolerated nature and non-teratogenic potential make it an attractive candidate for further investigation and potential incorporation into novel treatment strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 1312424-26-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,2,4,2 and 4 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1312424-26:
(9*1)+(8*3)+(7*1)+(6*2)+(5*4)+(4*2)+(3*4)+(2*2)+(1*6)=102
102 % 10 = 2
So 1312424-26-2 is a valid CAS Registry Number.
1312424-26-2Relevant articles and documents
Chemical Compounds
-
, (2011/07/06)
Novel diarylpyrimidine derivatives and pharmaceutically acceptable salts, solvates or hydrates thereof, designed to inhibit HIV reverse transcriptase, are provided, and a pharmaceutical composition containing the same, especially an anti-HIV agent. More s
